/2016

Forge Therapeutics to Participate in FBR Healthcare Series to Highlight New Approaches to Fighting Infections

San Diego, Calif., April 12, 2016 – Forge Therapeutics, Inc., a biotechnology company discovering innovative therapeutics using a breakthrough drug discovery platform targeting [...]

2017-10-10T16:17:30-07:00April 11th, 2016|

Forge Therapeutics to Present at the Needham & Company’s 15th Annual Healthcare Conference

San Diego, Calif., April 5, 2016 – Forge Therapeutics, Inc., a biotechnology company discovering innovative therapeutics using a breakthrough drug discovery platform targeting [...]

2017-10-10T16:20:39-07:00April 4th, 2016|

Forge Therapeutics and Active Motif to Collaborate on Epigenetic Research and Drug Discovery: Goal to advance ‘drugability’ of Jumonji KDMs

San Diego, Calif., March 28, 2016 – Forge Therapeutics, Inc., a biotechnology company discovering innovative therapeutics using a breakthrough drug discovery platform targeting [...]

2017-10-10T16:21:01-07:00April 4th, 2016|

Forge Therapeutics Co-Founder to Showcase Thought Leadership in Metalloenzymes at the 251st American Chemical Society National Meeting

San Diego, Calif., March 10, 2016 – Forge Therapeutics, Inc., a biotechnology company discovering innovative therapeutics using a breakthrough drug discovery platform targeting [...]

2017-10-09T17:40:32-07:00March 10th, 2016|

Forge Therapeutics to Present at the BIOCOM Global Life Science Partnering Conference

San Diego, Calif., February 18, 2016 – Forge Therapeutics, Inc., a biotechnology company discovering innovative therapeutics using a breakthrough drug discovery platform targeting [...]

2017-10-09T17:43:25-07:00February 18th, 2016|
Load More Posts